Concurrent 3C: Impossible is nothing: New opportunities for opioid dependence treatment in resource-constrained settings
Tracks
.
| Thursday, October 10, 2024 |
| 11:15 AM - 12:15 PM |
| MC2 |
Speaker
Ms Catherina Timmermans
Technical Manager, Strategy
Unitaid
Welcome & Introductions
11:15 AM - 11:20 AMBiography
Dr Niklas Luhmann
Technical Officer
WHO
Update of WHO guidelines for the treatment of opioid dependence management and of opioid overdose
11:20 AM - 11:25 AMBiography
Niklas Luhmann is a medical doctor with a Master of Science in Public Health from the University of Berlin. He has been working for more than 15 years on access to healthcare related to HIV and viral hepatitis prevention, testing and treatment. He joined WHO headquarters in Geneva in 2019.
Dr. Kimberly Green
Global Program Leader, Primary Health Care
PATH
Research framework on LADB
11:25 AM - 11:30 AMBiography
Nico Clark
University of Queensland
Experiences of using long-acting OAT formulations in Australia and other high-income settings
11:30 AM - 11:37 AMBiography
Valeria Hrytsenko
Ukranian Public Health Centre, Ministry of Health, Ukraine
Continuation of opioid agonist treatment during a humanitarian crisis of war: lessons learned from Ukraine
11:37 AM - 11:44 AMBiography
Oleg Huley
Patients perspectives
11:44 AM - 11:50 AMBiography
Mr Oleksiy Kvitkovskyi
Director
VOLNa-Donbas RC
Patients perspectives
11:44 AM - 11:50 AMBiography
Mr Ernst Wisse
Harm Reduction Advisor
Medecins Du Monde
Preparing for introducing long-acting buprenorphine in Tanzania : challenges and opportunities
11:50 AM - 11:53 AMBiography
With a background as a nurse, Ernst has worked as a fieldworker and later as a manager in multiple Harm Reduction programs in several LMIC countries. He holds a master degree in public health from the LSHTM, and is currently the Harm Reduction expert for the medical NGO, Médecins du Monde.
INHSU 2024
Questions & Discussion
11:53 AM - 12:15 PMBiography
Chair
Catherina Timmermans
Technical Manager, Strategy
Unitaid
